← All trials
NCT06031727
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 4, 2023
- Primary completion
- Dec 31, 2024
- Completion date
- Jun 27, 2025
- First posted
- Sep 11, 2023
- Last posted
- Nov 13, 2023
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- HuidaGene Therapeutics Co., Ltd.Lead sponsor
- Fudan UniversityCollaborator
- Tianjin Medical UniversityCollaborator
- HuidaGene Therapeutics Co., Ltd.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.